Skip to main content
Caplight Logo









Canwell Biotech Ltd.

Canwell Biotech Ltd.

Private
GuangzhouHealthcare & Life Scienceshttp://canwellbiotech.com/

Last Round

Series A

Extension

Aug 1, 2022

Total Funding Raised

$46.2M

Company Overview

Canwell Biotech Ltd. is a biotechnology company that focuses on the research, development, and commercialization of innovative anti-tumor immunotherapies, including antibody-drug conjugates (ADCs) and cancer vaccines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antibody-drug conjugatesADCimmunotherapycancer vaccinesmall molecule-drug conjugateSMDCdrug discoverybiotechsolid tumor treatmentTLR7 agonistclinical-stage biopharmatargeted cancer therapyprecision medicinedrug licensingnext-gen oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Canwell Biotech Ltd. Comparables

Compare Canwell Biotech Ltd. with similar companies based on industry and business-model similarity.

Canwell Biotech Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Callio Therapeutics
87%
Eli Lilly and Company
83%
Coherent Biopharma
82%

Canwell Biotech Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionAug 1, 2022
Series AMar 18, 2022
Early FundingDec 1, 2020

Canwell Biotech Ltd. Investors

Notable investors and investment history

Canwell Biotech Ltd. investors
InvestorRounds
China Capital Management Co., Ltd.Series A
China Science and Technology Industry Investment ManagementSeries A, Early Funding
SDIC Venture CapitalSeries A Extension
Jiuyo Capital ManagementSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2020

    Raised capital from 国科投资.

Canwell Biotech Ltd. Filings

Explore SEC and related filing metadata, where available.

Canwell Biotech Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Canwell Biotech Ltd.'s valuation, stock price, and market status.

Is Canwell Biotech Ltd. a public or private company?

Canwell Biotech Ltd. is a private company.

What is the current stock price of Canwell Biotech Ltd.?

Canwell Biotech Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Canwell Biotech Ltd. worth (valuation)?

Valuation information for Canwell Biotech Ltd. is not publicly available.

Can I buy Canwell Biotech Ltd. stock?

Canwell Biotech Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Canwell Biotech Ltd.'s last funding round?

Canwell Biotech Ltd.'s most recent funding round was Series A Extension on August 1, 2022.

Who are the main investors in Canwell Biotech Ltd.?

Key investors in Canwell Biotech Ltd. include SDIC Venture Capital.

Will Canwell Biotech Ltd. IPO soon?

No public IPO plans have been announced for Canwell Biotech Ltd..

How can I track Canwell Biotech Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Canwell Biotech Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGuangzhou
Year Founded2018
Last FundingAug 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?